Skip to main content

Herpes Zoster - Prophylaxis News

Related terms: Shingles, Prophylaxis

US FDA Approves GSK’s Shingrix in a Prefilled Syringe Presentation

London, UK 17 July 2025 -- GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved a prefilled syringe presentation of Shingrix (GSK’s Recombinant Zoster ...

FDA Approves Prefilled Syringe Presentation for Shingles Vaccine

MONDAY, July 21, 2025 – The U.S. Food and Drug Administration has approved a prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted) for the prevention of shingles...

Live Zoster Vaccination Linked to Lower Risk for Cardiovascular Events

THURSDAY, May 8, 2025 – Live zoster vaccination is associated with a lower risk for overall cardiovascular events when compared with no vaccination, according to a study published online May 5 in...

Zoster Vaccine Has Dementia-Preventing or Delaying Effect

THURSDAY, April 3, 2025 – Zoster vaccination seems to have a dementia-preventing or dementia-delaying effect, according to a study published online April 2 in Nature. Markus Eyting, Ph.D., from...

Everything You Need to Know About Shingles & the Shingles Vaccine

SUNDAY, Dec. 8, 2024 – Shingles can strike anyone who had chickenpox when they were young, and the intense pain that can accompany this body rash has sidelined many a senior. Here, one expert...

Shingrix Approved in the US for Prevention of Shingles in Immunocompromised Adults

Philadelphia, London – 26 July 2021 – GlaxoSmithKline plc today announced that the US Food and Drug Administration (FDA) has approved Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Vaccination and Prophlaxis